ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

SXTPW 60 Degrees Pharmaceuticals Inc

0,0751
0,00 (0,00%)
30 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
60 Degrees Pharmaceuticals Inc SXTPW NASDAQ Equity Warrant
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 0,0751 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,0751 0,0751
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/05/202408:59GLOBEEnrollment in 60 Degrees Pharmaceuticals Clinical Trial of..
20/05/202408:59GLOBE60 Degrees Pharmaceuticals Funds Babesia spp Testing in..
15/05/202414:45GLOBE60 Degrees Pharmaceuticals Announces First Quarter 2024..
08/05/202408:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
02/05/202408:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
03/04/202408:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
14/03/202408:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
20/02/202409:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
08/02/202409:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
31/01/202413:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
30/01/202411:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
22/01/202409:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
16/01/202409:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
26/12/202309:59GLOBE60 Degrees Pharma Announces IRB Approval of Phase IIA Study..
15/11/202309:29GLOBE60 Degrees Pharma Announces Type C Meeting with FDA to..
19/10/202309:31GLOBE60 Degrees Pharma to Present Review of Safety, Efficacy Data..
12/10/202317:16GLOBE60 Degrees Pharmaceuticals Suspends Phase IIB Study of..
18/09/202317:16GLOBE60 Degrees Pharma Withdraws COVID Phase IIB IND, Will..
06/09/202308:31GLOBE60 Degrees Pharmaceuticals to Participate in H.C. Wainwright..
30/08/202308:32GLOBE60 Degrees Pharmaceuticals Study Results Published by New..
22/08/202308:31GLOBE60 Degrees Pharmaceuticals Receives Additional U.S. Patent..
15/08/202308:31GLOBE60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB..
31/07/202308:59GLOBE60 Degrees Pharmaceuticals Awarded Canadian Patent Covering..
14/07/202313:39GLOBE60 Degrees Pharmaceuticals Announces Closing of Initial..
12/07/202313:29GLOBE60 Degrees Pharmaceuticals Announces Pricing of Initial..